한국어
English
日本語
中文(简体)
Doptelett 20 mg (Abatrombopac Malate)
23.6mg
Tablet · Prescription medication
Handok Co., Ltd.
Avatrombopag maleate is an ingredient that increases platelet count and reduces the risk of bleeding.
MFDS ingredient code M284876
Avatrombopag maleate is a platelet-generating agent used in patients with a deficiency of platelets in the blood. It is primarily used for the treatment of thrombocytopenia and is applicable to blood and fluid-related disorders.
This ingredient binds to receptors involved in platelet production, promoting the production of platelets in the bone marrow. As a result, the platelet count increases and the risk of bleeding decreases.
Approved uses differ by product. Check each product's information for its actual use.
Unlike conventional platelet-generating agents, Avatrombopag maleate can be administered orally and selectively acts on specific receptors to facilitate effective and safe increases in platelet count.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.